Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell‐Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae - Nag - 2016 - Scandinavian Journal of

In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease - Biology of Blood and Marrow Transplantation

A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections: Molecular Therapy - Nucleic Acids

IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells

Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling

JNJ-54271074 blocked mouse Th17 differentiation and IL-17A production

Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review - ScienceDirect

A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission

CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During Early Mycobacterium tuberculosis Infection in Mice

Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia

Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell‐Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae - Nag - 2016 - Scandinavian Journal of

Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia

Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome

Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell‐Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae - Nag - 2016 - Scandinavian Journal of